Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GS-9620
GS-9620
Gilead Sciences' $14 Billion-Per-Year Threat
Motley Fool
Sun, 03/18/18 - 11:26 am
Gilead Sciences
GS-9620
GS-9722
HIV
Is Gilead Sciences Trying to Put Itself Out of Business?
Motley Fool
Wed, 03/14/18 - 09:31 pm
Gilead Sciences
hepatitis C
HIV
GS-9620
PGT121
Gilead's Looming Challenge: A Plan B For HBV
Seeking Alpha
Tue, 11/22/16 - 11:35 am
Gilead Sciences
hepatitis B
GS-9620
After Curing Hepatitis C, Gilead Works to Vanquish More Viruses
Bloomberg
Mon, 08/17/15 - 07:15 pm
Gilead Sciences
hepatitis C
hepatitis B
GS-9620
viruses